On Thursday, the “Make America Healthy Again” commission released its first report on the potential contributors of chronic ...

GLP-1 receptor agonists may reduce risk for obesity-related cancers among people with diabetes compared with dipeptidyl ...

The FDA has told vaccine manufacturers to expand the warning labels on their COVID-19 shots with more information about the ...

A subretinal injection of ATSN-201 gene therapy demonstrated promising results in patients with X-linked retinoschisis in a ...

The National Kidney Foundation Council of Advanced Practice Providers conducts an online survey every 2 years to assess changes in the workforce and utilization of advanced practice providers in ...

It is a challenging time to be a women’s health care provider, but there are ways physicians can reclaim their power while ...

The FDA cleared an investigational new drug application for a phase 2 trial of GRF312 ophthalmic solution, an immunoglobulin ...

A machine learning model may be reliable for determining risk for postpartum depression, underscoring the need for greater ...

In this video, Jay Chhablani, MD, discusses findings presented at the ARVO meeting from a phase 2b study evaluating suprachoroidal axitinib for neovascular age-related macular degeneration.

Shakira J. Grant, MBBS, MSCR, is working to make visible the lived experiences and real-world barriers that patients with ...

A newborn baby presents to the local ED after a home delivery with no prenatal care. The pregnancy was diagnosed by a local ...

After a heart attack, patients with ADHD may have poorer outcomes due to low participation in follow-ups and behavioral risk ...